EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Changes in Core Temperature Following Administration of FC5, a Blood–Brain Carrier Fused with Neurotensin in Mice, Rats and Non-Human Primates

Alvaro Yogi, Etienne Lessard, Eric Brunette, Christie E Delaney iD, Arsalan S Haqqani iD, Anna Robotham iD, Wael Alata, Maria J Moreno, Danica B Stanimirovic

Cells · 2026

DOI: 10.3390/cells15191770 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cells, 2026. Verfasst von Alvaro Yogi und 8 weiteren Autor:innen. Beteiligte Einrichtung: Human Health Therapeutics Research Centre, National Research Council Canada, Ottawa, ON K1A 0R6, Canada. Hauptthemen laut MEDLINE: Neurotensin, Blood-Brain Barrier, Recombinant Fusion Proteins, Immunoglobulin Fc Fragments. Die Arbeit nennt 53 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Development of therapies and pharmacological management of central nervous system diseases is significantly hampered by the presence of the highly selective blood–brain barrier (BBB). Receptor-mediated transcytosis (RMT) has proven to be a robust mechanism for delivering a wide variety of therapeutic modalities across the BBB. The present study describes the use of a neurotensin-based pharmacodynamic model to evaluate the brain penetrating capacity of FC5, a well-characterized RMT shuttle. Here we produce fusion molecules of FC5 with human Fc and neurotensin and show that intact but not C-terminally clipped neurotensin proteins containing either FC5 (FC5Fc-neurotensin) or a non-BBB-crossing control (A20.1Fc-neurotensin) retain the ability to activate neurotensin receptor type 1. In in vivo studies, intravenous administration of FC5Fc-neurotensin, but not neurotensin alone or A20.1Fc-neurotensin, induced a drop in the core body temperature in both rats and mice. We further extended these findings to non-human primates, demonstrating the ability of FC5 to cross the BBB in this species. Collectively, our results further support the potential of FC5 in delivering payloads across the BBB. The neurotensin model of hypothermia is also validated as a pharmacodynamic approach for assessing brain delivery, albeit with some necessary considerations into the molecular characterization of fusion constructs before in vivo evaluation.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

NeurotensinBlood-Brain BarrierRecombinant Fusion ProteinsImmunoglobulin Fc FragmentsBody TemperatureAnimalsHumansRatsMiceReceptors, NeurotensinMaleTranscytosis

Stichwörter der Autor:innen

FC5blood–brain barriercore temperatureneurotensinnon-human primatereceptor-mediated transcytosissingle domain antibody

Substanzen

NeurotensinReceptors, NeurotensinRecombinant Fusion ProteinsImmunoglobulin Fc Fragmentsneurotensin type 1 receptor

Autor:innen und Institutionen

  • Human Health Therapeutics Research Centre, National Research Council Canada, Ottawa, ON K1A 0R6, Canada.
  • Biology Program, Division of Science, New York University Abu Dhabi, Saadiyat Island Campus, Abu Dhabi P.O. Box 129188, United Arab Emirates.

ORCID-Profile: Christie E Delaney, Arsalan S Haqqani, Anna Robotham

Zitieren

APA

Yogi, A., Lessard, E., Brunette, E., Delaney, C. E., Haqqani, A. S., Robotham, A., Alata, W., Moreno, M. J., & Stanimirovic, D. B. (2026). Changes in Core Temperature Following Administration of FC5, a Blood–Brain Carrier Fused with Neurotensin in Mice, Rats and Non-Human Primates. Cells. https://doi.org/10.3390/cells15191770

Vancouver

Yogi A, Lessard E, Brunette E, Delaney CE, Haqqani AS, Robotham A, et al. Changes in Core Temperature Following Administration of FC5, a Blood–Brain Carrier Fused with Neurotensin in Mice, Rats and Non-Human Primates. Cells. 2026. doi:10.3390/cells15191770

BibTeX
@article{Yogi2026,
  author = {Yogi, Alvaro and Lessard, Etienne and Brunette, Eric and Delaney, Christie E and Haqqani, Arsalan S and Robotham, Anna and Alata, Wael and Moreno, Maria J and Stanimirovic, Danica B},
  title = {Changes in Core Temperature Following Administration of FC5, a Blood–Brain Carrier Fused with Neurotensin in Mice, Rats and Non-Human Primates},
  journal = {Cells},
  year = {2026},
  doi = {10.3390/cells15191770}
}
Kostenlos starten →